Vaccines and Antiviral Drugs in Pandemic Preparedness

Por Monto, Arnold S.
Publicado em 2006

Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years: An Expanding Framework for Influenza Detection, Prevention and Control

Por Monto, Arnold S.
Publicado no Influenza Other Respir Viruses (2018)

Letters to the Editor

Por Francis, Thomas, Monto, Arnold S.
Publicado em 1969

Reply to Sullivan and Kelly and Skowronski et al

Por Monto, Arnold S., Ohmit, Suzanne E.
Publicado em 2013

Pandemic Influenza: An Inconvenient Mutation

Por LAYNE, SCOTT P., MONTO, ARNOLD S., TAUBENBERGER, JEFFERY K.
Publicado em 2009

Abdeljaber and Colleagues Respond

Por Abdeljaber, Mutee H., Monto, Arnold S., Tilden, Robert L., Schork, Anthony
Publicado em 1993

Reduced Reaction Frequencies with Repeated Inactivated or Live-attenuated Influenza Vaccination

Por Ohmit, Suzanne E., Gross, Jonathan, Victor, John C., Monto, Arnold S.
Publicado em 2008

The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review

Por Malosh, Ryan E., Martin, Emily T., Ortiz, Justin R., Monto, Arnold S.
Publicado no Vaccine (2018)

533 Persistence of Antibody to Influenza Hemagglutinin over Two Influenza Seasons

Por Petrie, Joshua G., Ohmit, Suzanne E., Cross, Rachel, Monto, Arnold
Publicado no Open Forum Infect Dis (2014)

The Doctrine of Original Antigenic Sin: Separating Good From Evil

Por Monto, Arnold S., Malosh, Ryan E., Petrie, Joshua G., Martin, Emily T.
Publicado no J Infect Dis (2017)

Host-Parasite Interaction in Patients with Infections due to Escherichia coli. I. The Serogrouping of E. coli from Intestinal and Extraintestinal Sources

Por Vosti, Kenneth L., Goldberg, Leonard M., Monto, Arnold S., Rantz, Lowell A.
Publicado em 1964

Flexible Label-Free Quantitative Assay for Antibodies to Influenza Virus Hemagglutinins

Por Carney, Paul J., Lipatov, Aleksandr S., Monto, Arnold S., Donis, Ruben O., Stevens, James
Publicado em 2010

Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures

Por Petrie, Joshua G., Ohmit, Suzanne E., Johnson, Emileigh, Cross, Rachel T., Monto, Arnold S.
Publicado em 2011

Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination

Por Petrie, Joshua G., Ohmit, Suzanne E., Johnson, Emileigh, Truscon, Rachel, Monto, Arnold S.
Publicado no J Infect Dis (2015)

997. Protection of Unvaccinated Individuals by Influenza Vaccine Coverage of Household Contacts

Por Malosh, Ryan E, Evans, Richard, Martin, Emily T, Petrie, Joshua G, Monto, Arnold S
Publicado no Open Forum Infect Dis (2018)

Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain

Por Garretson, Tyler A., Petrie, Joshua G., Martin, Emily T., Monto, Arnold S., Hensley, Scott E.
Publicado no Vaccine (2018)

Frequency of Acute Respiratory Illnesses and Circulation of Respiratory Viruses in Households With Children Over 3 Surveillance Seasons

Por Monto, Arnold S., Malosh, Ryan E., Petrie, Joshua G., Thompson, Mark G., Ohmit, Suzanne E.
Publicado no J Infect Dis (2014)

Facemasks, Hand Hygiene, and Influenza among Young Adults: A Randomized Intervention Trial

Por Aiello, Allison E., Perez, Vanessa, Coulborn, Rebecca M., Davis, Brian M., Uddin, Monica, Monto, Arnold S.
Publicado em 2012

Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community

Por Ainslie, Kylie E. C., Haber, Michael J., Malosh, Ryan E., Petrie, Joshua G., Monto, Arnold S.
Publicado no Stat Med (2017)

Stochastic processes constrain the within and between host evolution of influenza virus

Por McCrone, John T, Woods, Robert J, Martin, Emily T, Malosh, Ryan E, Monto, Arnold S, Lauring, Adam S
Publicado no eLife (2018)